Cleveland Clinic and Greatbatch were among the investors in a round that will support development of Cardionomic's heart failure treatment device.
US-based medical device developer Cardionomic secured $20m yesterday in a series A round featuring healthcare provider Cleveland Clinic and medical device producer Greatbatch Medical.
The round also included venture capital firm New Enterprise Associates, as well as additional, undisclosed investors.
The capital will support development of a neuromodulation treatment for Acute Decompensated Heart Failure (ADHF), a condition where fluid accumulates in the lungs and other tissues of a patient that has experienced heart failure.
Cardionomic’s device will treat ADHF by…
